Benzocaine
Cat.No:IB1530 Solarbio
CAS:1994/9/7
Molecular Formula:C9H11NO2
Molecular Weight:165.19
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to light yellow Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Membrane Transporter & Ion Channel >
BenzocaineCAS:1994/9/7
Molecular Formula:C9H11NO2
Molecular Weight:165.19
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to light yellow Solid
Qty:
Size:
CAS | 1994/9/7 |
Name | Benzocaine |
Molecular Formula | C9H11NO2 |
Molecular Weight | 165.19 |
Solubility | Soluble in DMSO |
Purity | ≥98% |
Appearance | White to light yellow Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 202-303-5 |
MDL | MFCD00007892 |
SMILES | CCOC(=O)C1=CC=C(C=C1)N |
InChIKey | BLFLLBZGZJTVJG-UHFFFAOYSA-N |
InChI | InChI=1S/C9H11NO2/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6H,2,10H2,1H3 |
PubChem CID | 2337 |
Target Point | Sodium Channel |
Passage | Membrane Transporter&Ion Channel |
Background | Benzocaine, the active ingredient in many over-the-counter anesthetic creams, such as mouth ulcer products, works by reversibly inactivating voltage-dependent sodium channels. |
Biological Activity | Benzocaine 与所有其它局部麻醉药 (LAs) 一起,作用电压门控Na+通道的共同受体,其在 +30 mV 下测得的 IC50 值为0.8 mM。[1-3] |
IC50 | 0.8mM(Na+ channel)[1]. |
In Vitro | 苯佐卡因以剂量依赖性方式阻断μ1野生型Na +电流。当施加+ 30mV的测试电位时,估计抑制50%Na +电流的苯佐卡因浓度(IC50)为约0.8mM。苯并卡因(从6.6到9.9 mV)也显著降低了h∞曲线的斜率。 μ1-N1584A的突变也显著增加了苯佐卡因的效力。在1mM时,苯佐卡因阻断约55%的野生型Na +电流但约95%的μ1-N1584A突变电流。与野生型相比,苯佐卡因似乎与N1584A突变体中的LA受体结合更强[1]。 Caz +摄取的抑制发生在较低的苯佐卡因浓度(IC50 = 40.3±1.2mM),而不是影响酶活性[2]。 |
In Vivo | 一种常见的含苯佐卡因麻醉剂局部应用于以下物种:狗,家养短毛猫,Long-Evans大鼠,Sprague-Dawley大鼠,雪貂,恒河猴,食蟹猴,猫头鹰猴,新西兰白兔,小型猪,ICR小鼠,C3H小鼠和C57BL / 10SnJ小鼠。除小鼠和大鼠外,所有动物均接受2秒喷雾至鼻咽粘膜,估计剂量为56mg。对啮齿动物的口腔粘膜进行2秒喷雾可为这些动物提供过大量的液体。几个月后在狗中重复该研究以确认低反应。在大多数测试的动物中观察到对苯佐卡因喷雾的反应,在给药后15至30分钟内反应达到峰值[3]。 |
Data Literature Source | [1]. Wang GK et al. A common local anesthetic receptor for benzocaine and etidocaine in voltage-gated mu1 Na+ channels. Pflugers Arch. 1998 Jan;435(2):293-302. [2]. Di Croce D et al. Drug action of benzocaine on the sarcoplasmic reticulum Ca-ATPase from fast-twitch skeletal muscle. Naunyn Schmiedebergs Arch Pharmacol. 2015 Nov;388(11):1163-70. [3]. Davis JA,et al. Benzocaine-induced methemoglobinemia attributed to topical application of the anesthetic in several laboratory animal species. Am J Vet Res. 1993 Aug;54(8):1322-6 |
Unit | Bottle |
Specification | 500mg 1g |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.